CVE-2024-10390

Elfsight Telegram Chat CC <= 1.1.0 - Missing Authorization to Authenticated (Subscriber+) Stored Cross-Site Scripting

Description

The Elfsight Telegram Chat CC plugin for WordPress is vulnerable to unauthorized modification of data to a missing capability check on the 'updatePreferences' function in all versions up to, and including, 1.1.0. This makes it possible for authenticated attackers, with subscriber-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Category

6.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.04%
Affected: Elfsight Elfsight Telegram Chat CC
Published at:
Updated at:

References

Link Tags
https://www.wordfence.com/threat-intel/vulnerabilities/id/07244763-3482-4cfb-8ae4-d19f312011aa?source=cve
https://codecanyon.net/item/elfsight-telegram-chat/25288599

Frequently Asked Questions

What is the severity of CVE-2024-10390?
CVE-2024-10390 has been scored as a medium severity vulnerability.
How to fix CVE-2024-10390?
To fix CVE-2024-10390, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-10390 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-10390 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-10390?
CVE-2024-10390 affects Elfsight Elfsight Telegram Chat CC.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.